FIELD: medicine, infectology.
SUBSTANCE: one should introduce rhoncoleukin in standard dosages and standard mode in combination with corbiculin for internal intake per 2 g once daily after meals, being pre-dissolved in 50 ml water, at 8-wk-long course. The present innovation enables to decrease the size of liver, favors regression of disease clinical manifestations in shorter period of time and normalization of detoxicational, protein-synthetic, pigment functions of liver and prolonged remission of the disease mentioned due to corbiculin and rhoncoleukin synergism.
EFFECT: higher efficiency of therapy.
3 dwg, 2 ex, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENTS WITH CHRONIC VIRAL HEPATITIS TYPE C, GENOTYPE 3a | 2009 |
|
RU2400229C1 |
METHOD FOR PREDICTING THE RESULTS OF TREATING PATIENTS WITH CHRONIC HEPATITIS C WITH INTERFERON-ALPHA PREPARATIONS | 2005 |
|
RU2287825C1 |
METHOD OF PREVENTION OF CHRONIC VIRAL HEPATITIS TYPE C RECURRENT AFTER VIRUS REMISSION | 2007 |
|
RU2348412C1 |
METHOD OF ARRESTING HEPATITE "C" CHRONISATION | 2007 |
|
RU2331436C1 |
METHOD FOR PREDICTION OF ANTIVIRAL THERAPY (AVT) EFFICACY IN CHRONIC HEPATITIS B (CHB) | 2011 |
|
RU2454666C1 |
METHOD FOR BASIC TREATMENT OF CHRONIC VIRAL HEPATITIS C | 2005 |
|
RU2306134C2 |
METHOD OF TREATMENT OF CHRONIC VIRAL HEPATITIS TYPE C | 2006 |
|
RU2345787C2 |
METHOD FOR CORRECTING CYTOLYTIC SYNDROME IN CHRONIC HEPATITIS CASES | 2004 |
|
RU2275926C2 |
METHOD FOR PREDICTING EFFICIENCY OF INTERFERONOTHERAPY AT CHRONIC HEPATITIS B | 2005 |
|
RU2287826C1 |
METHOD FOR TREATING CHRONIC DIFFUSE HEPATIC DISEASES DUE TO APPLYING THE COURSE OF INTRAVENOUS INJECTIONS OF SODIUM HYPOCHLORITE SOLUTIONS | 2004 |
|
RU2275921C2 |
Authors
Dates
2005-12-10—Published
2004-05-19—Filed